Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Black Diamond Therapeutics (BDTX) Debt to Equity (2018 - 2020)

Black Diamond Therapeutics' Debt to Equity history spans 2 years, with the latest figure at $0.0 for Q3 2020.

  • For Q3 2020, Debt to Equity changed N/A year-over-year to $0.0; the TTM value through Sep 2020 reached $0.0, changed N/A, while the annual FY2018 figure was -$0.11, N/A changed from the prior year.
  • Debt to Equity reached $0.0 in Q3 2020 per BDTX's latest filing, up from $0.0 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.0 in Q1 2020 to a low of -$0.11 in Q4 2018.